export default function EpitalonOverviewPanel() {
  return (
    <div className="reta-overview">

      <p className="reta-overview__opener">
        Epitalon (also spelled Epithalon) is a synthetic four-amino-acid peptide derived from Soviet-era pineal gland research. The longevity community uses it for telomere extension and anti-aging goals, and the evidence from decades of Russian trials is real &mdash; small RCTs in elderly cohorts showing reduced mortality. But the telomerase mechanism cuts both ways: the same pathway that could slow cellular aging also enables cancer cell immortality. Anyone evaluating this compound needs to hold that tension honestly rather than dismissing it.
      </p>

      <div className="reta-overview__profile">
        <div className="reta-overview__profile-label">Profile 1</div>
        <h3 className="reta-overview__profile-heading">The Longevity-Curious Person &mdash; Interested in living better for longer</h3>
        <blockquote className="reta-overview__profile-think">&ldquo;I keep seeing Epitalon in longevity circles with references to telomeres and anti-aging. Is this actually doing something or is it another supplement industry story?&rdquo;</blockquote>
        <p className="reta-overview__profile-why-heading">Why they&rsquo;re excited</p>
        <ol className="reta-overview__profile-why">
          <li><strong>Telomere shortening is a real hallmark of cellular aging</strong><br />Every time a cell divides, its protective chromosome caps (telomeres) get a bit shorter. When they get short enough, cells stop dividing normally. Telomerase is the enzyme that can lengthen them, and it becomes less active as we age. Epitalon is proposed to reactivate that enzyme. This isn&rsquo;t made-up biology &mdash; it&rsquo;s a real and actively researched area.</li>
          <li><strong>The Russian trial data is not zero</strong><br />Decades of research from Khavinson&rsquo;s group in St. Petersburg showed reduced all-cause mortality and lower rates of age-related diseases in elderly cohorts who received the compound. The findings are consistent in direction across multiple studies. This isn&rsquo;t a completely unvalidated idea &mdash; it&rsquo;s a real signal with real limitations.</li>
        </ol>
        <p className="reta-overview__profile-check-heading">Reality check</p>
        <p className="reta-overview__profile-check">The Russian trials are small, have methodological limitations, and have not been independently replicated at scale by Western research groups. The telomerase mechanism is the defining concern: cancer cells exploit the same pathway to become immortal. If you have any personal or family history of cancer, this compound is not appropriate. The research peptide products available are not pharmaceutical-grade &mdash; what&rsquo;s actually in the vial is unverified without a third-party certificate of analysis. The most commonly reported early experience is improved sleep quality, which reflects the pineal gland connection, not necessarily anti-aging action. Net: real signal, real limitations, real unknowns &mdash; approach with informed caution, not with certainty.</p>
      </div>

      <div className="reta-overview__profile">
        <div className="reta-overview__profile-label">Profile 2</div>
        <h3 className="reta-overview__profile-heading">The Athlete &mdash; Anti-aging and recovery alongside training</h3>
        <blockquote className="reta-overview__profile-think">&ldquo;I&rsquo;m in my 40s, still training hard, and I&rsquo;m thinking about longevity as part of my recovery stack. Epitalon keeps coming up in that context &mdash; what&rsquo;s actually useful to know?&rdquo;</blockquote>
        <p className="reta-overview__profile-why-heading">Why they&rsquo;re excited</p>
        <ol className="reta-overview__profile-why">
          <li><strong>The sleep quality effects align well with recovery goals</strong><br />The most consistently reported near-term effect &mdash; deeper, more vivid sleep &mdash; is consistent with what athletes are actively trying to optimize. If epitalon genuinely improves sleep architecture through the pineal/melatonin pathway, that has real recovery value independent of whether the longevity claims pan out.</li>
          <li><strong>Athletes aging into their 40s think about cellular resilience differently</strong><br />Recovery between sessions gets harder, inflammation takes longer to resolve, and tissue repair slows. The idea of a compound that operates at the cellular maintenance level &mdash; rather than just masking symptoms &mdash; resonates with athletes who are thinking about sustainable performance over decades, not just the next competition.</li>
        </ol>
        <p className="reta-overview__profile-check-heading">Reality check</p>
        <p className="reta-overview__profile-check">There is no validated short-term biomarker that tells you epitalon is working for longevity purposes. Telomere length testing is commercially available but has significant measurement variability and doesn&rsquo;t reliably predict individual outcomes. The Russian trial populations were elderly patients &mdash; not healthy athletes in their 40s &mdash; and whether findings translate to this very different population is genuinely unknown. The cancer concern applies equally to athletes: any history of hormone-sensitive cancer makes this a hard stop regardless of fitness level. Net: the sleep effects may be the honest near-term value; the longevity claims are years-scale and not validated for your specific use case.</p>
      </div>

      <div className="reta-overview__profile">
        <div className="reta-overview__profile-label">Profile 3</div>
        <h3 className="reta-overview__profile-heading">The Biohacker &mdash; Telomere science, pineal biology, longevity mechanisms</h3>
        <blockquote className="reta-overview__profile-think">&ldquo;I want to understand the actual telomerase activation mechanism &mdash; specifically how a four-amino-acid peptide could influence hTERT expression &mdash; and where the science genuinely runs out versus where the community is extrapolating.&rdquo;</blockquote>
        <p className="reta-overview__profile-why-heading">Why they&rsquo;re excited</p>
        <ol className="reta-overview__profile-why">
          <li><strong>The hTERT activation hypothesis is scientifically interesting and not fully disproven</strong><br />In vitro data shows epitalon can activate telomerase and extend telomeres in human fibroblasts. The proposed mechanism involves epigenetic regulation of hTERT expression &mdash; the tetrapeptide may interact with chromatin or transcription factor complexes that normally suppress hTERT in somatic cells. Whether this translates from cell culture to whole-organism pharmacology via subcutaneous injection is the unresolved question, and it&rsquo;s a real one, not a settled one.</li>
          <li><strong>The pineal gland mechanism provides a separate, better-characterized pathway</strong><br />Epitalon appears to restore age-related decline in pineal melatonin synthesis. The pineal connection has more direct mechanistic support: the pineal gland&rsquo;s circadian regulatory role declines with age, and restoring melatonin amplitude has documented effects on circadian biology, sleep architecture, and potentially immune function. This is a more pharmacokinetically plausible mechanism for a short peptide than direct hTERT regulation.</li>
        </ol>
        <p className="reta-overview__profile-check-heading">Reality check</p>
        <p className="reta-overview__profile-check">The cancer tension is not resolvable by dose reasoning. Telomerase is not expressed at high levels in most healthy somatic cells precisely because unrestricted telomere extension enables indefinite cell division &mdash; which is cancer. Every tissue in your body that might have occult pre-malignant cells would theoretically be affected by systemic telomerase activation. The community convention of short cycling courses reflects appropriate uncertainty, not a solved problem. Dismissing the Russian trial evidence is intellectually dishonest; taking it as proof of efficacy in research-grade peptides is equally dishonest. The product quality gap between what Khavinson used and what research peptide suppliers provide is real and meaningful. Net: the mechanistic story is genuinely interesting, the safety unknowns are genuine, and the community discourse around this compound underweights both the cancer concern and the product quality problem.</p>
      </div>

      <div className="reta-overview__bottom">
        <p className="reta-overview__bottom-heading">The honest bottom line</p>
        <div className="reta-overview__bottom-cols">
          <div className="reta-overview__bottom-col">
            <p className="reta-overview__bottom-col-heading">What Epitalon is NOT</p>
            <ul className="reta-overview__bottom-list">
              <li>Not a proven longevity compound &mdash; the Russian trial data is real but limited; independent large-scale replication does not exist</li>
              <li>Not appropriate for anyone with personal or family cancer history &mdash; the telomerase activation mechanism is a genuine concern, not a theoretical one to rationalize around</li>
              <li>Not pharmaceutical-grade &mdash; no regulated production standard exists; product quality is entirely supplier-dependent</li>
              <li>Not a short-term fix &mdash; the longevity effects in trials were measured over years, not weeks</li>
              <li>Not proven safe for long-term continuous use &mdash; community cycling conventions reflect uncertainty, not solved biology</li>
            </ul>
          </div>
          <div className="reta-overview__bottom-col">
            <p className="reta-overview__bottom-col-heading">What makes it interesting</p>
            <ul className="reta-overview__bottom-list">
              <li>Decades of consistent-direction findings from Khavinson&rsquo;s group &mdash; not zero evidence, real evidence with real limitations</li>
              <li>Telomerase activation and telomere biology is a genuine frontier of aging research, not marketing language</li>
              <li>The pineal gland connection provides a plausible mechanism for the near-term sleep quality effects many users report</li>
              <li>A four-amino-acid peptide with potential epigenetic effects is pharmacologically unusual and genuinely interesting to study</li>
              <li>The cancer tension makes it one of the most intellectually honest tests of a biohacker&rsquo;s risk-benefit reasoning</li>
            </ul>
          </div>
        </div>
      </div>

    </div>
  );
}
